Mitsubishi UFJ Morgan Stanley Securities’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-280
Closed -$22K – 124
2022
Q4
$22K Buy
280
+100
+56% +$8.11K 0.19% 68
2022
Q3
$15K Hold
180
– – 0.2% 87
2022
Q2
$16K Hold
180
– – 0.02% 89
2022
Q1
$20K Buy
+180
New +$19K 0.02% 79
2014
Q4
$18K Hold
250
– – 0.04% 155
2014
Q3
$15K Sell
250
-250
-50% -$15.9K 0.04% 179
2014
Q2
$32K Buy
500
+480
+2,400% +$29.2K 0.09% 76
2014
Q1
$1K Sell
20
-20
-50% -$1.17K ﹤0.01% 251
2013
Q4
$2K Buy
+40
New +$2.27K ﹤0.01% 236

Other funds holding MDT

Mitsubishi UFJ Morgan Stanley Securities's MDT Position: Q1 2023 in Review

Mitsubishi UFJ Morgan Stanley Securities sold out of Medtronic (MDT) in Q1 2023, closing a stake of 280 shares — an estimated $22K sold.

Mitsubishi UFJ Morgan Stanley Securities first reported a position in MDT in Q4 2013 and held it in 9 quarters. The position peaked at $32K in Q2 2014. 1,990 funds tracked by Wall St. Rank hold MDT as of Q1 2023.

  • Mitsubishi UFJ Morgan Stanley Securities reported no remaining Medtronic position as of Q1 2023 after selling out during the quarter.
  • Mitsubishi UFJ Morgan Stanley Securities sold 280 Medtronic shares in Q1 2023, an estimated $22K.
  • Mitsubishi UFJ Morgan Stanley Securities first reported a position in Medtronic in Q4 2013 and held it in 9 quarters.
  • Mitsubishi UFJ Morgan Stanley Securities's Medtronic position peaked at $32K in Q2 2014.
  • 1,990 funds tracked by Wall St. Rank held Medtronic as of Q1 2023.

Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q1 2023, filed 2 May 2023.